{"version":"1.0","provider_name":"Avalere Health Advisory","provider_url":"https:\/\/advisory.avalerehealth.com","title":"Updated: Key Considerations for MFP Effectuation and the 340B Rebate Model | Avalere Health Advisory","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"qZT5ry5Gqw\"><a href=\"https:\/\/advisory.avalerehealth.com\/insights\/key-considerations-for-mfp-effectuation-and-the-340b-rebate-model\">Updated: Key Considerations for MFP Effectuation and the 340B Rebate Model<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/advisory.avalerehealth.com\/insights\/key-considerations-for-mfp-effectuation-and-the-340b-rebate-model\/embed#?secret=qZT5ry5Gqw\" width=\"600\" height=\"338\" title=\"&#8220;Updated: Key Considerations for MFP Effectuation and the 340B Rebate Model&#8221; &#8212; Avalere Health Advisory\" data-secret=\"qZT5ry5Gqw\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n<\/script>\n","thumbnail_url":"https:\/\/advisory.avalerehealth.com\/wp-content\/uploads\/2024\/08\/32917-1-EmilyDonaldson-400x600-1.jpg","thumbnail_width":600,"thumbnail_height":400,"description":"340B Ceiling Price, MFP Interaction and Potential Rebate Models The\u00a0340B Drug Pricing Program\u00a0was established to help certain safety-net providers, known as covered entities, purchase covered outpatient drugs at substantial discounts (i.e., 340B ceiling price). With the change of administration and a new Congress, there continues to be a great deal of stakeholder interest in the&hellip;"}